Ebooks & White Papers
Dotmatics offers a collection of expert-authored white papers and ebooks covering topics such as optimizing outsourcing to CROs, biotech investment strategies, ELN buying guidance, chemicals and materials innovation, data integration with GraphPad Prism, biologics and small molecule drug discovery optimization, lab data and workflow automation, and addressing data challenges in therapeutic candidate development, with options to request customized demos tailored to R&D goals.
Browse our downloads featuring content from expert industry leaders.
White Papers and Ebooks
- Optimizing Outsourcing to CROs in Early Small Molecule Drug Discovery — White Paper
- Navigating the Biotech Investment Paradox — Ebook
- ELN Buyer's Guide — Ebook
- A Strategy for Chemicals and Materials Innovation — Ebook
- Shine Light on your Dark Data with the GraphPad Prism & Dotmatics Integration — White Paper
- Optimizing Biologics Discovery — Ebook
- Guide to Optimizing Small Molecule Drug Discovery — Ebook
- Unlocking the Value of Data and Workflow Automation in the Lab | Pharma IQ — White Paper
- Solving Critical Data Challenges for Chemically-modified, Biologically-based Therapeutic Candidates — White Paper
See What Data-Driven Discovery Looks Like
Get in touch for a customized demo built around your R&D goals.
Related
Simplify your laboratory workflow management with Dotmatics
Dotmatics offers a unified scientific R&D platform that streamlines laboratory workflow management by integrating various scientific applications, automating data extraction, cleaning, and harmonization into FAIR formats, thereby reducing manual data handling, enhancing collaboration, and accelerating the R&D cycle to help life sciences organizations bring new therapies to market faster.
Addressing Inefficient R&D Workflows
The blog discusses how legacy, fragmented R&D systems hinder innovation in complex, multi-domain scientific research by creating silos and inefficiencies, and presents Dotmatics’ unifying platform as a comprehensive solution that integrates diverse tools, data, and teams to enable smarter collaboration, governed data use, and AI-driven automation for faster, more rigorous innovation.
Data Evolution in Pharma: The Spread of Multimodal
The pharmaceutical industry is shifting from single-mode to multimodal drug discovery, incorporating diverse therapeutic modalities like biologics, gene therapies, and small molecules, but this evolution presents significant challenges in integrating heterogeneous R&D data and technologies, necessitating advanced, compatible platforms to enable efficient collaboration and leverage AI-driven insights for faster, cost-effective drug development.
Biologics Drug Discovery
The Dotmatics Biology Solution offers comprehensive end-to-end data management and analysis tools tailored for biologics drug discovery—including antibodies, CAR-T cells, and RNA therapeutics—facilitating collaborative workflows in molecular cloning, protein production, biologics registration, and assay data analysis to accelerate innovation and streamline complex research processes.
About Dotmatics
Dotmatics is a science-driven company with a mission to build the world’s most powerful scientific R&D platform by uniting best-in-class software applications into a flexible, data-driven ecosystem used by over 2 million scientists worldwide, enabling collaboration, automation, and analysis to accelerate innovation and address global challenges in health, environment, and safety.
Faster Workflows, Better UX, Deeper Integration: Inside ELN & Data Discovery Platform 7.1
Dotmatics ELN & Data Discovery Platform 7.1 introduces a major interface and navigation overhaul, enhanced scientific functionalities for Biology and Chemicals & Materials R&D, and seamless integration capabilities, all designed to streamline workflows, improve user experience, and enable more efficient collaboration and data-driven decision-making in scientific research and administration.